ADLM 2025 Conference Preview – Sessions Rundown

Published: June 30, 2025

From July 27 through July 31, in Chicago, Illinois, the Association for Diagnostics & Laboratory Medicine (ADLM) is having its annual conference. The ADLM 2025 Clinical Lab Expo features expert insights, presentations of the latest research and technologies, and plenty of opportunities for networking and developing collaborations.

With hundreds of speakers, educational sessions, and product categories scheduled at the conference, we wanted to sort through and highlight some of the exciting sessions currently planned.

The following sessions are accurate as of June 24, 2025. Consult the event’s official website for the most up-to-date schedule.

Emerging Technologies to Enable Remote Monitoring and Micro Sampling for Greater Health Equity

July 28, 7:30AM – 8:30AM
Description: This session offers clinical chemists a platform to stay updated and engage in discussions about the latest technological advancements in remote and micro sampling. The roundtable will feature an interactive format, including a showcase of new sampling devices which are designed to address existing gaps.

ADLM Guidance on Emergency Department Toxicology Testing: Impact on Your Laboratory

July 28, 10:30AM – 12:00PM
Description: Attendees will learn how the laboratory can adapt to the new ADLM Academy recommendations for recreational drug and non-recreational toxicology testing. Analytes, matrices, methodologies, regulatory considerations, test interpretation, test menus, and turn-around times will be covered.

Best Practices in Patient Impact Analysis Using Case Studies from Pediatric and Rural Healthcare Settings

July 28, 12:30PM – 1:30PM
Description: This interactive session will include case studies from pediatric and rural healthcare setting to explore best practices in patient impact analysis, with focus on chart review components, level of harm assignment, and corrective action plan development.

Diabetes in Gestation and Postpartum: How the Lab Can Help

July 29, 7:30AM – 8:30AM
Description: At this roundtable session, attendees will hear discussion on the importance of diabetes screening during and after pregnancy; how the clinical lab can play a pivotal role in the diagnosis and management of GDM during and after delivery; and examples of easy strategies that can increase compliance for diabetes screening during and after pregnancy.

Opportunities and Challenges for Leveraging Generative Artificial Intelligence Technologies in the Clinical Laboratory

July 29, 7:30AM–8:30AM
Description: This interactive session will provide a non-technical overview of emergent GAI tools and their possible application scenarios in Laboratory Medicine, with a focus on industry trends and the rapidly expanding literature evaluating their utility.

Role of component Resolved Testing in Food Allergies: From Peanuts to Tick-borne Red Meat Allergies

July 29, 2:30PM – 4:00PM
Description: This session will primarily focus on component resolved testing and its role in the diagnosis and management of common food allergies including peanut, tree nuts, alpha-gal syndrome and others.

Continuous Glucose Monitoring: Does More Data Improve Diabetes Care?

July 30, 7:30AM – 8:30AM
Description: This session explores whether studies using continuous glucose monitoring (CGM) in hospitals support their use to improve patient outcomes. Attendees will gain critical insights into the benefits, challenges, and clinical implications of CGM data in patients, helping them make informed decisions about CGM usage.

Drug Screening in the Clinical Lab: Case Studies and Future Directions

July 30, 12:30PM – 1:30PM
Description: The session will outline the current practices in drugs of abuse screening, primarily utilizing immunoassay screening methods as they are cost effective and provide fast turnaround time. The session will explore the science behind these methods, explaining the principle of their operation and understanding their strengths and limitations. The session will then present real-life clinical case studies that highlight the complex and nuanced nature of drug abuse screening.

The Urgent Threat of Plastics to Human Health, and What We Can Do About It

July 31, 8:45AM – 10:00AM
Description: Much of the public concern about the impact of plastics has been focused on visible or microscopic plastic, but the gravest concerns about human health impacts of plastics relate to the release of monomers and additives that are widely detected in the general population, especially in communities located near production facilities. This session explores the science behind the health impacts that plastic have and the paradigm shift needed in laboratory medicine.